Cerus Corporation

CERS Healthcare Medical Devices

In the quarter to June 2026, revenue grew 5.28%, EPS grew 50.3%, free cash flow fell 20.9% and total debt fell 23.5%, each against the same quarter a year earlier.

2.20 0.06 −2.65%
Market cap
$455.5M
P/E
0.0×
Fwd P/E
−81.3×
Dividend yield
—
F-score
5/9
Altman Z
−4.00
Beneish M
−2.87
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
1.35 1.68 1.44 2.36
P/FCF ratio
1,815.53 354.35 0.00 0.00
P/Operating CF
158.28 63.33 (115.89) (220.09)
P/B ratio
4.90 6.04 5.17 8.28
Price to Tangible BV
5.01 6.17 5.28 8.44
EV/Sales
1.38 1.68 1.46 2.40
EV/EBITDA
0.00 0.00 0.00 9,004.57
EV/Operating CF
87.33 81.38 135.92 245.88
EV/FCF
1,853.58 355.26 (293.71) (324.93)
Quick Ratio
1.22 1.12 1.02 1.02
Current Ratio
1.89 1.73 1.63 1.83
Net Debt/EBITDA
3.95 (4.07) 47.38 (6.19)
Debt/Assets
39.46% 37.81% 38.06% 31.64%
Debt/Equity
1.36 1.29 1.24 0.92
Asset Turnover
1.12 1.11 1.14 1.19
Operating CF/Net income
(101.42) (2.84) 1.86 0.91
Capex/Depreciation
(4.80) (3.33) (0.52) (1.89)
Interest Coverage
0.58 (0.33) (0.19) (1.08)
Research and Development Expense of Revenue
26.27% 25.38% 24.26% 22.73%
Selling, General and Administrative Expense of Revenue
30.91% 32.25% 33.31% 36.12%
Intangible Assets out of Total Assets
0.01 0.01 0.01 0.01
Share Based Compensation of Revenue
9.34% 7.63% 8.19% 8.68%
Graham Net Nets
0.05 0.04 0.06 0.04
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(5.25%) (3.89%) (2.75%) (1.20%)
Free Cash Flow Yield
0.06% 0.28% (0.34%) (0.31%)
Revenue per Share
0.31 0.34 0.31 0.32
Operating CF per Share
0.01 0.03 (0.02) (0.01)
Capex per Share
(0.01) (0.01) 0.00 0.00
Free Cash Flow per Share
0.00 0.03 (0.02) (0.02)
Cash per Share
0.41 0.43 0.41 0.28
Shareholders Equity per Share
0.32 0.34 0.35 0.35
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
0.32 0.34 0.35 0.35
Free Cash Flow
0.09 4.89 (3.28) (3.53)
Working Capital
78.69 73.58 67.96 71.52
Capital Expenditures
(1.83) (1.31) (0.23) (0.87)
Net Current Asset Value
14.15 17.49 20.72 22.84
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.03 0.02 0.00 0.01
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
27.07 30.08 27.83 31.18
Average Payables
20.67 24.85 29.73 32.02
Average Inventory
44.84 47.13 54.64 60.17
Average Assets
202.36 211.39 214.84 209.13
Average Common Equity
58.24 60.93 62.26 63.44

Fold the line items

Columns are period end dates